6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine

C85H105F3N26O8 — CID 159014110

IUPAC6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine
SMILESCCCCOc1nc(N)c2[nH]c(=O)n(Cc3cccc(Cn4cccn4)c3)c2n1.CCNC(=O)Oc1nc2c(N)nc(OCCOC)nc2n1Cc1cccc(CN2CCCC2)c1.Cc1nc2c(N)nc(OCC(F)(F)F)nc2n1Cc1cccc(CN2CCCC2)c1.Cc1nc2c(N)nc(OCC3CC3)nc2n1Cc1cccc(CN2CCCC2)c1
InChIInChI=1S/C23H31N7O4.C22H28N6O.C20H23F3N6O.C20H23N7O2/c1-3-25-23(31)34-22-26-18-19(24)27-21(33-12-11-32-2)28-20(18)30(22)15-17-8-6-7-16(13-17)14-29-9-4-5-10-29;1-15-24-19-20(23)25-22(29-14-16-7-8-16)26-21(19)28(15)13-18-6-4-5-17(11-18)12-27-9-2-3-10-27;1-13-25-16-17(24)26-19(30-12-20(21,22)23)27-18(16)29(13)11-15-6-4-5-14(9-15)10-28-7-2-3-8-28;1-2-3-10-29-19-24-17(21)16-18(25-19)27(20(28)23-16)13-15-7-4-6-14(11-15)12-26-9-5-8-22-26/h6-8,13H,3-5,9-12,14-15H2,1-2H3,(H,25,31)(H2,24,27,28);4-6,11,16H,2-3,7-10,12-14H2,1H3,(H2,23,25,26);4-6,9H,2-3,7-8,10-12H2,1H3,(H2,24,26,27);4-9,11H,2-3,10,12-13H2,1H3,(H,23,28)(H2,21,24,25)
InChIKeyJSWGDFJTHMNJTM-UHFFFAOYSA-N
MW1675.94 g/mol
LogP10.81
Rot. Bonds31

About 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine

6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine (PubChem CID 159014110) has the molecular formula C85H105F3N26O8 and a molecular weight of 1675.94 g/mol. Its IUPAC name is 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine.

Molecular Properties

Compound Name6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine
PubChem CID159014110
Molecular FormulaC85H105F3N26O8
Molecular Weight1675.94 g/mol
Exact Mass1674.86
IUPAC Name6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine
SMILESCCCCOc1nc(N)c2[nH]c(=O)n(Cc3cccc(Cn4cccn4)c3)c2n1.CCNC(=O)Oc1nc2c(N)nc(OCCOC)nc2n1Cc1cccc(CN2CCCC2)c1.Cc1nc2c(N)nc(OCC(F)(F)F)nc2n1Cc1cccc(CN2CCCC2)c1.Cc1nc2c(N)nc(OCC3CC3)nc2n1Cc1cccc(CN2CCCC2)c1
InChIInChI=1S/C23H31N7O4.C22H28N6O.C20H23F3N6O.C20H23N7O2/c1-3-25-23(31)34-22-26-18-19(24)27-21(33-12-11-32-2)28-20(18)30(22)15-17-8-6-7-16(13-17)14-29-9-4-5-10-29;1-15-24-19-20(23)25-22(29-14-16-7-8-16)26-21(19)28(15)13-18-6-4-5-17(11-18)12-27-9-2-3-10-27;1-13-25-16-17(24)26-19(30-12-20(21,22)23)27-18(16)29(13)11-15-6-4-5-14(9-15)10-28-7-2-3-8-28;1-2-3-10-29-19-24-17(21)16-18(25-19)27(20(28)23-16)13-15-7-4-6-14(11-15)12-26-9-5-8-22-26/h6-8,13H,3-5,9-12,14-15H2,1-2H3,(H,25,31)(H2,24,27,28);4-6,11,16H,2-3,7-10,12-14H2,1H3,(H2,23,25,26);4-6,9H,2-3,7-8,10-12H2,1H3,(H2,24,26,27);4-9,11H,2-3,10,12-13H2,1H3,(H,23,28)(H2,21,24,25)
InChIKeyJSWGDFJTHMNJTM-UHFFFAOYSA-N
XLogP10.81
TPSA410.47 Ų
H-Bond Donors6
H-Bond Acceptors32
Rotatable Bonds31
Heavy Atoms122
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001675.94
LogP ≤ 510.81
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine?
The IUPAC name of 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine (CID 159014110) is 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine.
What is the SMILES notation for 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine?
The canonical SMILES for 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine is CCCCOc1nc(N)c2[nH]c(=O)n(Cc3cccc(Cn4cccn4)c3)c2n1.CCNC(=O)Oc1nc2c(N)nc(OCCOC)nc2n1Cc1cccc(CN2CCCC2)c1.Cc1nc2c(N)nc(OCC(F)(F)F)nc2n1Cc1cccc(CN2CCCC2)c1.Cc1nc2c(N)nc(OCC3CC3)nc2n1Cc1cccc(CN2CCCC2)c1.
What is the InChIKey of 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine?
The InChIKey is JSWGDFJTHMNJTM-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H31N7O4.C22H28N6O.C20H23F3N6O.C20H23N7O2/c1-3-25-23(31)34-22-26-18-19(24)27-21(33-12-11-32-2)28-20(18)30(22)15-17-8-6-7-16(13-17)14-29-9-4-5-10-29;1-15-24-19-20(23)25-22(29-14-16-7-8-16)26-21(19)28(15)13-18-6-4-5-17(11-18)12-27-9-2-3-10-27;1-13-25-16-17(24)26-19(30-12-20(21,22)23)27-18(16)29(13)11-15-6-4-5-14(9-15)10-28-7-2-3-8-28;1-2-3-10-29-19-24-17(21)16-18(25-19)27(20(28)23-16)13-15-7-4-6-14(11-15)12-26-9-5-8-22-26/h6-8,13H,3-5,9-12,14-15H2,1-2H3,(H,25,31)(H2,24,27,28);4-6,11,16H,2-3,7-10,12-14H2,1H3,(H2,23,25,26);4-6,9H,2-3,7-8,10-12H2,1H3,(H2,24,26,27);4-9,11H,2-3,10,12-13H2,1H3,(H,23,28)(H2,21,24,25).
What are the key properties of 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine?
6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine has a molecular weight of 1675.94 g/mol, XLogP of 10.81, 31 rotatable bonds, 6 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 6-amino-2-butoxy-9-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]-7H-purin-8-one;[6-amino-2-(2-methoxyethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-8-yl] N-ethylcarbamate;2-(cyclopropylmethoxy)-8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]purin-6-amine;8-methyl-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2-(2,2,2-trifluoroethoxy)purin-6-amine is sourced from PubChem (CID 159014110), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).